However, HES5 is also a WNT/β-catenin signaling target gene [53] and tumor suppressor [54,55], while HES6 has been shown to be an oncogene [56,57] and activator of WNT/β-catenin signaling [58]. The gene discussed is HES6; the disease is neoplasm.